I would agree GN. Would seem to be selling themselves well short agreeing to a TO at 70c being so close to FDA submission and hopefully approval. Not sure the announcement will be about a TO - possibly just confirmation that Cephalon have taken up their option (hopefull!). Anyway as you say GD time will tell. Fingers crossed.
I-man
- Forums
- ASX - By Stock
- CXS
- promising biotech
promising biotech, page-13
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some